Medical Devices New Zealand

New Zealand Biological Age Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

New Zealand Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $10.1 Mn Placeholder estimate
Estimate 2025 $11.4 Mn 1.1% of the global market
Projected 2034 $34.5 Mn 202.8% Adds $23.1 Mn over 9 forecast years
CAGR 2025–2034 13.1% Faster than 82% of 160 Medical Devices markets here
Key players 5 Companies profiled
  • New Zealand is 1.11% of the global market.
  • In APAC, the largest is China at $93.8 Mn.
  • Fastest growing: India at 16.4% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$23.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biological Age Testing Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $10.1 Mn — —
2025 (base) $11.4 Mn +$1.3 Mn —
2026 (forecast) $12.9 Mn +$1.5 Mn +13.1%
2027 (forecast) $14.6 Mn +$1.7 Mn +27.9%
2028 (forecast) $16.5 Mn +$1.9 Mn +44.7%
2029 (forecast) $18.6 Mn +$2.2 Mn +63.6%
2030 (forecast) $21.1 Mn +$2.4 Mn +85.1%
2031 (forecast) $23.8 Mn +$2.8 Mn +109.3%
2032 (forecast) $26.9 Mn +$3.1 Mn +136.7%
2033 (forecast) $30.5 Mn +$3.5 Mn +167.7%
2034 (forecast) $34.5 Mn +$4.0 Mn +202.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand Biological Age Testing Market Analysis at a glance
Market size, 2025$11.4 Mn placeholder estimate
Forecast, 2034$34.5 Mn placeholder estimate
Growth (CAGR), 2025–203413.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, channel and end user (see all)
Key playersTruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all)
Regulator in New ZealandMedsafe (WAND)Source: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Biological Age Testing Market Analysis Executive Summary

Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.

Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).

Bar chart: New Zealand Biological Age Testing market size, 2024–2034, placeholder estimates. $10.1 Mn in 2024, $11.4 Mn in 2025 and $34.5 Mn in 2034, 13.1% CAGR.
New Zealand Biological Age Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Biological Age Testing Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.

Competitive Landscape for Biological Age Testing Market in New Zealand

The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biological Age Testing Market in New Zealand

Biological Age Testing in New Zealand: rules, payment and health figures

Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2] People aged 65 and over: 17.6% of people in 2025, the latest World Bank figure for New Zealand.⁠[3]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biological Age Testing right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biological Age Testing in context

New Zealand compared

  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 5th highest of the 18 countries we cover in APAC.[1]
  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 17 countries we cover in APAC.[2]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 17 countries we cover in APAC.[3]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biological Age Testing market in New Zealand?
Placeholder estimate: about $11.4 Mn in 2025, rising to about $34.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biological Age Testing market in New Zealand growing?
Placeholder estimate: about 13.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biological Age Testing market report cover?
The report splits the market by test (Epigenetic Clocks, Blood Biomarker Panels, Telomere Tests, Multi-Omic Tests), channel (Direct-to-Consumer, Clinics, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Biological Age Testing market?
Key players include TruDiagnostic, Tally Health, InsideTracker, GlycanAge and Elysium Health.
What is driving the Biological Age Testing market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
Who regulates Biological Age Testing in New Zealand?
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
What does World Bank report for New Zealand?
People aged 65 and over: 17.6% of people in 2025, the latest World Bank figure. Source: World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
How much research is published on Biological Age Testing?
PubMed lists 803 papers on Biological Age Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in New Zealand

See all

Related on geriatric and genomics

See the topic